Ayca Erkin-Cakmak, MD, MPH

Title(s)Assistant Professor, Pediatrics
SchoolSchool of Medicine
Address1550 Fourth Street, #550A
San Francisco CA 94158
ORCID ORCID Icon0000-0003-1580-9163 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Istanbul, Cerrahpasa School of Medicine, TurkeyMD07/2003Doctor of Medicine
    University of Istanbul, Istanbul School of Medicine, Turkey06/2009Pediatric Residency
    University of California, Berkeley, United StatesMPH05/2013Maternal and Child Health
    University of California, San Francisco, United States05/2019Pediatric Endocrinology, Fellowship
    University of California, San Francisco, United States06/2021Pediatrics Residency
    University of California, San Francisco, United States6/2022Advanced Research in Pediatrics, Fellowship

    Collapse Overview 
    Collapse Overview
    Dr. Ayca Erkin-Cakmak is a pediatric endocrinologist who cares for children with conditions related to hormonal issues. These include obesity, thyroid disorders, hormone-related growth disorders, metabolic syndrome (having a combination of health factors that increases the risk of heart disease and type 2 diabetes), and endocrine conditions associated with iron overload from thalassemia (an inherited blood disorder that can lead to anemia).

    Erkin-Cakmak's research focuses on how exposures to certain chemicals in early childhood can affect the endocrine system and later development of obesity and metabolic syndrome. She is also interested in endocrine issues related to blood transfusions given to treat thalassemia.

    Erkin-Cakmak earned her medical degree from Istanbul University Cerrahpasa Faculty of Medicine. She completed a residency in pediatrics and a fellowship in pediatric endocrinology as well as a fellowship in advanced research in pediatrics at UCSF. She also earned a master of public health degree from the University of California, Berkeley.

    Erkin-Cakmak is a member of the Pediatric Endocrine Society, Endocrine Society and Obesity Society. She is originally from Turkey.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. 6518 A Family Affair: A Case of Idiopathic Infantile Hypercalcemia. Journal of the Endocrine Society. 2024 Oct 5; 8(Supplement_1):bvae163.1393. Hu HT, Gao GJ, Ekhlaspour EL, Wallerstein WR, Erkin-Cakmak EA. .
      View in: Publisher Site   Mentions:
    2. Prenatal and childhood exposure to persistent organic pollutant mixtures and cardiometabolic outcomes in young adulthood. ISEE Conference Abstracts. 2024 Aug 15; 2024(1). Mora MA, Erkin Cakmak EA, Rosa RM, Kogut KK, Harley HK, Eskenazi EB. .
      View in: Publisher Site   Mentions:
    3. PSUN160 Transfusion Related Endocrinopathies and Thalassemia (TREAT) Study. Journal of the Endocrine Society. 2022 Nov 1; 6(Suppl 1):a443-a443. Erkin-Cakmak EA, Ahmad AT, Rishon RA, Weyhmiller WM, Fung FE, Lodish LM, Lal LA. .
      View in: Publisher Site   Mentions:
    4. Effects of Isocaloric Fructose Restriction on Ceramide Levels in Children with Obesity and Cardiometabolic Risk: Relation to Hepatic De Novo Lipogenesis and Insulin Sensitivity. Nutrients. 2022 Mar 30; 14(7). Olson E, Suh JH, Schwarz JM, Noworolski SM, Jones GM, Barber JR, Erkin-Cakmak A, Mulligan K, Lustig RH, Mietus-Snyder M. PMID: 35406045; PMCID: PMC9002884.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    5. Abstract 16511: Isocaloric Fructose Restriction Improves Postprandial Chylomicron and VLDL Excursions in Adolescents With Obesity by Reducing Angiopoietin-Like Protein 3 and Apolipoprotein CIII. Circulation. 2020 Nov 17; 142(Suppl_3). Bains BY, Erkin-Cakmak EA, Caccavello CR, Mulligan MK, Noworolski NS, Schwarz SJ, Lustig LR, Gugliucci GA. .
      View in: Publisher Site   Mentions:
    6. 1360-P: Infertility Is Not Associated with Clinical Factors in Women with Type 1 Diabetes (T1D). Diabetes. 2020 Jun 1; 69(Supplement 1):1360-p. ERKIN-CAKMAK EA, BAILEY BR, CALHOUN CP, CAKMAK CH, WONG WJ. .
      View in: Publisher Site   Mentions:
    7. SUN-690 HNF4A Mutation in Siblings with Diazoxide Responsive Congenital Hyperinsulinism. Journal of the Endocrine Society. 2020 May 8; 4(Supplement_1):sun-690-. Erkin-Cakmak EA, Chesser CH, Shieh SJ, Ferrara FC, Gitelman GS, Capodanno CG. .
      View in: Publisher Site   Mentions:
    8. Short-Term Isocaloric Fructose Restriction Improves Postprandial Lipoprotein Subclass Profiles. Atherosclerosis. 2019 Aug 1; 287:e59-e60. Gugliucci GA, Bains BY, Caccavello CR, Wen WM, Erkin-Cakmak EA, Mulligan MK, Lustig LR, Noworolski NS, Schwarz SJ. .
      View in: Publisher Site   Mentions:
    9. Isocaloric Fructose Restriction Reduces Serum d-Lactate Concentration in Children With Obesity and Metabolic Syndrome. J Clin Endocrinol Metab. 2019 07 01; 104(7):3003-3011. Erkin-Cakmak A, Bains Y, Caccavello R, Noworolski SM, Schwarz JM, Mulligan K, Lustig RH, Gugliucci A. PMID: 30869790; PMCID: PMC6553815.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    10. SAT-269 Insulin 101: Quality Education Strategies for Trainees (QuEST). Journal of the Endocrine Society. 2019 Apr 15; 3(Suppl 1). Lee LJ, Huang HA, Erkin-Cakmak EA, Buchanan BJ, Capodanno CG. .
      View in: Publisher Site   Mentions:
    11. Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity. Gastroenterology. 2017 09; 153(3):743-752. Schwarz JM, Noworolski SM, Erkin-Cakmak A, Korn NJ, Wen MJ, Tai VW, Jones GM, Palii SP, Velasco-Alin M, Pan K, Patterson BW, Gugliucci A, Lustig RH, Mulligan K. PMID: 28579536; PMCID: PMC5813289.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansCells
    12. Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome. Atherosclerosis. 2016 10; 253:171-177. Gugliucci A, Lustig RH, Caccavello R, Erkin-Cakmak A, Noworolski SM, Tai VW, Wen MJ, Mulligan K, Schwarz JM. PMID: 27451002.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    13. Erratum: "In Utero and Childhood Polybrominated Diphenyl Ether Exposures and Body Mass at Age 7 Years: The CHAMACOS Study". Environ Health Perspect. 2016 Apr; 124(4):A68. Erkin-Cakmak A, Harley KG, Chevrier J, Bradman A, Kogut K, Huen K, Eskenazi B. PMID: 27035790; PMCID: PMC4829980.
      View in: PubMed   Mentions:    Fields:    
    14. Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome. Obesity (Silver Spring). 2016 Feb; 24(2):453-60. Lustig RH, Mulligan K, Noworolski SM, Tai VW, Wen MJ, Erkin-Cakmak A, Gugliucci A, Schwarz JM. PMID: 26499447; PMCID: PMC4736733.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    15. In utero and childhood polybrominated diphenyl ether exposures and body mass at age 7 years: the CHAMACOS study. Environ Health Perspect. 2015 Jun; 123(6):636-42. Erkin-Cakmak A, Harley KG, Chevrier J, Bradman A, Kogut K, Huen K, Eskenazi B. PMID: 25738596; PMCID: PMC4455588.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansPHPublic Health
    16. A bridge to insulin pump therapy: twice-daily regimen with NPH and detemir insulins during initial treatment of youth with type 1 diabetes mellitus. Endocr Pract. 2011 Nov-Dec; 17(6):862-6. Cengiz E, Sherr JL, Erkin-Cakmak A, Weinzimer SA, Burke EN, Sikes KA, Urban AD, Tamborlane WV. PMID: 21550949.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    Ayca's Networks
    Concepts (74)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (8)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.